6606 — New Horizon Health Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMid Cap
- HK$6.47bn
- HK$5.15bn
- CNY764.96m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.8 | 58.3 | 70.6 | 213 | 765 |
Cost of Revenue | |||||
Gross Profit | 3.84 | 34.3 | 37.2 | 155 | 646 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 243 | 163 | 851 | 3,290 | 837 |
Operating Profit | -224 | -105 | -781 | -3,078 | -72.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -225 | -106 | -788 | -3,085 | -79.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -225 | -106 | -789 | -3,085 | -80.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -225 | -106 | -789 | -3,085 | -80.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -225 | -106 | -789 | -3,085 | -80.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.538 | -0.254 | -1.85 | -8.1 | -0.19 |
Dividends per Share |